Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

Presentation TCT 2025

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

Presenter: Zeyad Kholeif

October 27, 2025

Presentation TCT 2025

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

Presenter: Pushan Aggarwal

October 27, 2025

Presentation TCT 2023

STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors

Presenter: Sanjit Jolly

October 25, 2023

Presentation TCT 2022

TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

Presenter: Khawaja Akhtar

September 19, 2022

Presentation TCT 2022

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

September 19, 2022

Presentation TCT 2022

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Presenter: Davide Cao

September 18, 2022

Presentation TCT 2020

TCT 449: Direct Oral Anticoagulants vs. Warfarin Following Left Atrial Appendage Occlusion: A Study-Level Meta-Analysis

Presenter: Aravdeep Jhand

October 14, 2020

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Presenter: James B. Hermiller Jr, David Hildick-Smith, David R. Holmes Jr.

September 24, 2018

Presentation TCT 2017

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Samir R. Kapadia, David J. Moliterno

November 01, 2017

Presentation TCT 2017

What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants

Presenter: Robert A. Harrington, Kurt Huber, Freek W.A. Verheugt

November 01, 2017

Presentation TCT 2017

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy

Presenter: Robert A. Harrington, Kurt Huber, Renato D. Lopes

November 01, 2017

Presentation TCT 2016

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White

November 01, 2016

Presentation TCT 2016

What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT

Presenter: David P. Faxon, C. Michael Gibson, Freek W.A. Verheugt

November 01, 2016

Presentation TCT 2016

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT

Presenter: David P. Faxon, C. Michael Gibson, Christopher B. Granger

November 01, 2016

Presentation TCT 2016

Chronic Oral Anticoagulants: Limitations, Use Recommendations, and Investigational Agents

Presenter: Paul A. Gurbel, Christopher B. Granger

October 30, 2016

Presentation TCT 2015

Is There a Role for Oral Anticoagulants After PCI?

Presenter: Eric R. Bates, Neal S. Kleiman, C. Michael Gibson

October 15, 2015

Presentation TCT 2015

How Good Is LAA Closure Compared to Oral Anticoagulants? Results of Studies

Presenter: Russell A. Brandwein, Elizabeth M Perpetua

October 11, 2015

Presentation TCT 2014

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

Presenter: Vivian Lee

September 16, 2014

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

Presentation TCT 2014

Role of New Oral Anticoagulants and New ADP Antagonists in ACS Patients

Presenter: Roxana Mehran, Mohamed Sobhy

September 13, 2014

Advertisement

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors

TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

TCT 449: Direct Oral Anticoagulants vs. Warfarin Following Left Atrial Appendage Occlusion: A Study-Level Meta-Analysis

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT

Chronic Oral Anticoagulants: Limitations, Use Recommendations, and Investigational Agents

Is There a Role for Oral Anticoagulants After PCI?

How Good Is LAA Closure Compared to Oral Anticoagulants? Results of Studies

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Role of New Oral Anticoagulants and New ADP Antagonists in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content